Figure 2.
Monomer and dimer forms of 30Kc19. (A) SDS–PAGE result of the 30Kc19 protein under reducing and non-reducing conditions. (B) Native PAGE result of the 30Kc19 protein pre-treated with different SDS concentrations. (C) Native PAGE result of the 30Kc19, ovalbumin, and BSA proteins, each pre-treated with different SDS concentrations. (D) SEC result of 30Kc19, ovalbumin, and BSA proteins without SDS pre-treatment and with 1% w/v SDS pre-treatment. Concentration of 1 mg/mL was used for all proteins; 30Kc19, ovalbumin, and BSA.